trending Market Intelligence /marketintelligence/en/news-insights/trending/urJVXxLa2-2Vxa7pSUkbIg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Nanobiotix completes €25.1M private placement

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Nanobiotix completes €25.1M private placement

Nanobiotix SA closed a private placement of 1,596,527 new shares priced at €15.75 apiece to raise €25.1 million for the development of its cancer treatment NBTXR3.

The shares issued represent 9.99% of the French company.